The Patent Trial and Appeal Board had upheld most claims of CliniComp International Inc.'s U.S. Patent No. 6,665,647 on a system to allow independent healthcare enterprises to share access to certain applications, while maintaining sole access to their own unique healthcare systems.
Cerner and athenahealth’s appeal failed because they raised issues on appeal that they hadn’t presented to the board, the U.S. Court of Appeals for the Federal Circuit said in an unsigned nonprecedential opinion. ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
